Clovis Oncology, Inc. (CLVSQ)

Last Closing Price: 0.08 (2022-12-20)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Clovis Oncology, Inc. (CLVSQ) had Net Income of $-56.01M for the most recently reported fiscal quarter, ending 2022-09-30.

Figures for fiscal quarter ending 2022-09-30
Income Statement Financials
$30.66M
Net Income
$-56.01M
$8.61M
$22.05M
$74.90M
$-44.23M
$-11.74M
$-55.98M
$-55.98M
$-56.01M
$-56.01M
$-56.01M
$-56.01M
$-44.23M
$-41.78M
144.62M
144.62M
$-0.39
$-0.39
Balance Sheet Financials
$102.21M
$4.85M
$244.57M
$346.77M
$747.87M
--
$16.79M
$764.66M
$-417.89M
$-537.30M
$-417.89M
144.80M
Cash Flow Statement Financials
$-134.23M
$-0.20M
$53.18M
$143.43M
$58.32M
$-85.11M
$16.92M
--
--
Fundamental Metrics & Ratios
0.14
--
--
--
-1.05
71.93%
-144.26%
-144.26%
--
-182.56%
-182.68%
$-134.43M
--
--
--
0.09
0.75
1.58
57.10
13.40%
10.43%
-16.15%
13.40%
$-2.89
$-0.93
$-0.93